Linde stock ends 2025 lower as Wall Street shuts for New Year’s Day — what to watch next for LIN

Linde stock ends 2025 lower as Wall Street shuts for New Year’s Day — what to watch next for LIN

NEW YORK, January 1, 2026, 3:59 PM ET — Market closed

  • Linde shares last closed down 0.46% at $426.39 in the year’s final session.
  • U.S. stock markets are closed Thursday for New Year’s Day and reopen Friday.
  • Traders are turning to early-2026 macro signals and Linde’s next earnings update for direction.

Linde plc shares ended the year’s final trading day down 0.46% at $426.39, with U.S. markets closed on Thursday for the New Year’s Day holiday. Linde+1

The industrial-gases group, a steady large-cap in the materials space, often trades as a read-through on factory demand and large project activity. In holiday-thin conditions, even modest risk-off moves can show up quickly in defensives like LIN.

That matters heading into the first full week of 2026. Investors are positioning for how quickly growth cools or re-accelerates, and whether easing financial conditions translate into stronger volumes for industrial suppliers.

Wall Street closed slightly lower on Wednesday as investors took profits into year-end, with the S&P 500 down 0.74%, the Nasdaq off 0.76% and the Dow down 0.63%. “It’s perfectly fine in any bull market to have moments of cost,” said Giuseppe Sette, co-founder and president of Reflexivity, pointing to profit-taking when liquidity is low. Reuters

Linde’s closest U.S.-listed peer Air Products & Chemicals finished lower as well, reflecting the same cautious tone into the holiday break.

Technically, LIN ended near the middle of its recent range. The stock’s 52-week range is $387.78 to $486.38, putting it about 12% below its high and roughly 10% above its low. MarketWatch

Company fundamentals — not Thursday’s tape — remain the driver for most long-only holders. At its last quarterly update in late October, Linde followed an earnings beat with a cautious fourth-quarter outlook, citing weaker volumes in Europe and forecasting adjusted EPS, or earnings per share, of $4.10 to $4.20. Reuters

Pricing discipline and cost control will be the key watchpoints in the next report, alongside any update on volume trends across chemicals and manufacturing end-markets. Investors will also look for commentary on project ramp-ups and currency translation, both of which can swing reported growth.

Before the next session, traders will focus on whether Friday’s reopening brings a broader risk reset after year-end profit-taking, or a return to dip-buying that dominated much of 2025. Any shift in rate expectations tends to ripple through industrials, even those with relatively defensive cash flows.

For Linde specifically, the next major catalyst is its fourth-quarter results. Nasdaq’s earnings calendar currently points to an estimated report date of Feb. 5, though those dates can move; last year, Linde scheduled its fourth-quarter release for early February. Nasdaq+1

A second event investors have on the radar is the company’s planned leadership change at the board level. Linde has said CEO Sanjiv Lamba is set to take on the additional role of chairman effective Jan. 31, 2026. Linde

Stock Market Today

  • Asia's hidden small-cap gems with solid foundations attract attention
    January 1, 2026, 6:15 PM EST. Asia's small-cap cohort is drawing investor focus as U.S. momentum diverges. A screening tool highlights firms with solid fundamentals-debt-to-equity levels, revenue growth and earnings growth-and a resilient operational picture. For example, ISE Chemicals shows a debt-to-equity of 1.29%, revenue growth of 16.36% and earnings growth of 32.61% with a high health rating. Toho Bank carries a debt-to-equity of 114.83% but 38.28% earnings growth. Others like Cresco and Woori Technology Investment post positive metrics, while some names remain illiquid despite earnings momentum. IPO activity and market-cap scales frame the spread, with Simply Wall St Value Rating and SZSE tickers underscoring the sector breadth of Asia's undiscovered small-cap universe.
Corcept Therapeutics stock tanks on FDA relacorilant setback — what happens next for CORT
Previous Story

Corcept Therapeutics stock tanks on FDA relacorilant setback — what happens next for CORT

T-Mobile stock today: TMUS holds near $203 with U.S. markets shut; earnings update in focus
Next Story

T-Mobile stock today: TMUS holds near $203 with U.S. markets shut; earnings update in focus

Go toTop